Go Pro
→ If you keep cash in a U.S. bank account… read this NOW (From Banyan Hill Publishing) (Ad)tc pixel Free ARQT Stock Alerts

Arcutis Biotherapeutics (ARQT) Short Interest Ratio & Short Volume

Arcutis Biotherapeutics logo
$25.16 -0.13 (-0.51%)
Closing price 04:00 PM Eastern
Extended Trading
$25.16 0.00 (-0.02%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Arcutis Biotherapeutics Short Interest Overview

As of September 15, 2026, Arcutis Biotherapeutics (ARQT) had a short interest of 18.46 million shares sold short, representing 16.21% of the public float. This marks a 11.48% increase in short interest since the prior report. The short interest ratio (days to cover) is 8.5, meaning it would take 8.5 days of the average trading volume of 3.47 million shares to cover all short positions.

Current Short Interest
18,458,091 shares
Previous Short Interest
16,557,048 shares
Change Vs. Previous Month
11.48%
Dollar Volume Sold Short
$433.95 million
Short Interest Ratio
8.5 Days to Cover
Last Record Date
September 15, 2026
Outstanding Shares
125,690,000 shares
Short Percent of Float
16.21%
Today's Trading Volume
1,778,422 shares
Average Trading Volume
3,474,555 shares
Today's Volume Vs. Average
51%
Short Selling Arcutis Biotherapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Arcutis Biotherapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ARQT Short Interest Over Time

ARQT Days to Cover Over Time

ARQT Percentage of Float Shorted Over Time

Arcutis Biotherapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/202618,458,091 shares $433.95 million +11.5%16.2%8.54 $23.51
8/31/202616,557,048 shares $396.87 million +12.5%14.5%9.41 $23.97
8/14/202614,717,905 shares $385.46 million +16.0%12.9%8.04 $26.19
7/31/202612,686,384 shares $340.76 million -6.5%11.1%10.74 $26.86
7/15/202613,561,565 shares $376.74 million -3.3%12.0%9.34 $27.78
6/30/202614,019,289 shares $367.64 million -11.4%12.4%6.33 $26.22
6/15/202615,820,721 shares $404.69 million -2.5%14.0%10.04 $25.58
5/29/202616,226,183 shares $348.21 million -7.5%14.3%8.44 $21.46
5/15/202617,547,517 shares $374.11 million +4.0%15.5%7.3 $21.32
4/30/202616,879,909 shares $391.95 million +1.8%14.9%16.62 $23.22
4/15/202616,583,496 shares $407.62 million -1.3%14.6%15.62 $24.58
3/31/202616,801,149 shares $395.84 million +6.7%14.8%11.11 $23.56
3/13/202615,753,892 shares $358.40 million +3.0%14.0%12.56 $22.75
2/27/202615,292,517 shares $412.44 million -6.6%13.5%9.73 $26.97
2/13/202616,379,683 shares $423.58 million +2.3%14.5%14.06 $25.86
1/30/202616,010,858 shares $406.20 million +5.2%14.4%13.88 $25.37
1/15/202615,221,587 shares $401.24 million +1.4%13.7%8.41 $26.36
12/31/202515,011,554 shares $435.94 million +13.4%13.5%7.86 $29.04
12/15/202513,235,954 shares $383.18 million +9.8%11.9%6.78 $28.95
11/28/202512,059,791 shares $367.46 million -12.1%10.9%4.34 $30.47
11/14/202513,717,750 shares $342.94 million +1.8%12.4%5.45 $25.00
10/31/202513,479,227 shares $341.16 million -5.6%12.1%4.79 $25.31
10/15/202514,280,000 shares $308.88 million -1.2%13.1%8 $21.63
9/30/202514,450,000 shares $272.38 million -10.0%N/A8.1 $18.85
9/15/202516,050,000 shares $271.73 million -5.7%N/A9.5 $16.93
8/31/202517,020,000 shares $264.15 million -7.5%15.7%9.6 $15.52
8/15/202518,400,000 shares $310.78 million +10.6%N/A10.3 $16.89
7/31/202516,640,000 shares $242.61 million -3.7%15.3%8.9 $14.58
7/15/202517,270,000 shares $265.96 million -16.2%N/A9.1 $15.40
6/30/202520,600,000 shares $288.81 million +10.5%19.1%9.9 $14.02
6/15/202518,640,000 shares $250.34 million +11.1%17.3%8.5 $13.43
5/31/202516,780,000 shares $219.65 million +4.6%15.8%7.3 $13.09
5/15/202516,040,000 shares $218.63 million +5.9%15.1%6.6 $13.63
4/30/202515,140,000 shares $225.74 million +5.3%N/A6 $14.91
4/15/202514,380,000 shares $189.67 million -1.7%13.6%5.8 $13.19
3/31/202514,630,000 shares $228.81 million -3.2%13.8%6 $15.64
3/15/202515,110,000 shares $220.91 million -23.6%14.3%6.4 $14.62
2/28/202519,770,000 shares $270.65 million +12.1%18.7%9 $13.69
2/15/202517,640,000 shares $225.44 million -6.7%16.7%8.3 $12.78
1/31/202518,910,000 shares $250.37 million -6.5%N/A8.9 $13.24
They're not buying gold. They're buying this. (Ad)

Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, and Millennium by 122%. Kopernik Global made it their largest holding, owning roughly 8% of the company. It holds rights to an 88 million ounce deposit with existing roads, power, and permits that never expire. Market cap sits near $4 billion against a deposit worth hundreds of billions at current gold prices.tc pixel

See the name, ticker, and full file now
1/15/202520,220,000 shares $281.46 million -3.6%N/A9.5 $13.92
12/31/202420,970,000 shares $292.11 million -9.3%N/A10.2 $13.93
12/15/202423,110,000 shares $293.27 million -1.8%N/A11.2 $12.69
11/30/202423,530,000 shares $306.83 million -6.0%N/A11.8 $13.04
11/15/202425,020,000 shares $231.69 million -9.9%N/A12.8 $9.26
10/31/202427,760,000 shares $230.69 million -1.1%N/A13.1 $8.31
10/15/202428,060,000 shares $262.36 million +3.4%N/A13.7 $9.35
9/30/202427,130,000 shares $252.31 million +9.1%N/A12.7 $9.30
9/15/202424,860,000 shares $265.01 million +0.7%N/A10.5 $10.66
8/31/202424,680,000 shares $268.52 million +3.7%N/A9.9 $10.88
8/15/202423,800,000 shares $202.30 million +8.4%N/A9 $8.50
7/31/202421,950,000 shares $221.04 million -3.1%N/A7.8 $10.07
7/15/202422,660,000 shares $244.05 million +6.2%N/A8 $10.77
6/30/202421,340,000 shares $198.46 million -18.0%N/A7 $9.30
6/15/202426,020,000 shares $224.55 million +5.6%N/A8.7 $8.63
5/31/202424,640,000 shares $205.99 million +11.1%N/A7.7 $8.36
5/15/202422,170,000 shares $204.85 million +2.2%N/A6 $9.24
4/30/202421,690,000 shares $180.46 million +10.3%N/A5.7 $8.32
4/15/202419,660,000 shares $198.37 million +2.1%N/A4.3 $10.09
3/31/202419,260,000 shares $190.87 million +28.5%N/A4 $9.91
3/15/202414,990,000 shares $159.79 million -5.0%N/A2.8 $10.66
2/29/202415,780,000 shares $162.22 million -6.9%N/A2.6 $10.28
2/15/202416,940,000 shares $135.01 million +1.0%N/A2.9 $7.97
1/31/202416,780,000 shares $98.50 million -19.4%N/A3.1 $5.87
1/15/202420,830,000 shares $75.82 million +3.2%N/A4.1 $3.64
12/31/202320,180,000 shares $65.18 million +3.7%N/A4.2 $3.23
12/15/202319,460,000 shares $47.48 million -6.9%N/A4.8 $2.44
11/30/202320,900,000 shares $38.46 million +19.4%N/A8.2 $1.84
11/15/202317,510,000 shares $36.42 million +2.6%N/A8 $2.08
10/31/202317,070,000 shares $38.41 million +21.4%N/A8.5 $2.25
10/15/202314,060,000 shares $54.55 million +8.3%N/A8.7 $3.88
9/30/202312,980,000 shares $68.92 million -2.3%29.0%12.1 $5.31
9/15/202313,280,000 shares $90.44 million +6.4%29.7%13.1 $6.81
8/31/202312,480,000 shares $106.58 million -19.2%27.9%11.3 $8.54
8/15/202315,450,000 shares $130.86 million +1.6%34.5%12.8 $8.47
7/31/202315,210,000 shares $165.94 million +3.1%33.9%12.3 $10.91
7/15/202314,760,000 shares $139.33 million +0.2%32.8%11.9 $9.44
6/30/202314,730,000 shares $140.38 million +12.5%32.8%11.3 $9.53
6/15/202313,090,000 shares $133.78 million +0.4%29.1%10 $10.22
5/31/202313,040,000 shares $97.93 million -13.1%29.1%10.3 $7.51
5/15/202315,010,000 shares $154.60 million -2.5%33.7%13.1 $10.30
4/30/202315,390,000 shares $213.00 million +0.3%35.2%15.6 $13.84
4/15/202315,350,000 shares $213.21 million +1.5%35.1%15.5 $13.89
3/31/202315,120,000 shares $166.32 million +10.0%34.5%15.4 $11.00
3/15/202313,750,000 shares $152.76 million +11.1%31.4%14.9 $11.11
2/28/202312,380,000 shares $200.31 million +4.2%28.2%15 $16.18
2/15/202311,880,000 shares $203.62 million +10.1%27.2%15 $17.14
1/31/202310,790,000 shares $178.79 million +0.5%25.0%13 $16.57
1/15/202310,740,000 shares $151.65 million +0.9%24.9%13.1 $14.12
12/30/202210,650,000 shares $157.62 million +6.8%24.7%13.9 $14.80
They're not buying gold. They're buying this. (Ad)

Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, and Millennium by 122%. Kopernik Global made it their largest holding, owning roughly 8% of the company. It holds rights to an 88 million ounce deposit with existing roads, power, and permits that never expire. Market cap sits near $4 billion against a deposit worth hundreds of billions at current gold prices.tc pixel

See the name, ticker, and full file now
12/15/20229,970,000 shares $164.41 million +5.1%23.1%12.7 $16.49
11/30/20229,490,000 shares $163.51 million +17.9%22.0%12.6 $17.23
11/15/20228,050,000 shares $156.49 million +0.1%18.7%10.8 $19.44
10/31/20228,040,000 shares $142.15 million +17.4%19.2%12.1 $17.68
10/15/20226,850,000 shares $127.68 million +14.4%16.4%9.1 $18.64
9/30/20225,990,000 shares $114.47 million +15.2%14.3%8.6 $19.11
9/15/20225,200,000 shares $97.19 million +1.6%12.5%7.7 $18.69
8/31/20225,120,000 shares $137.98 million -1.7%12.4%8.4 $26.95
8/15/20225,210,000 shares $128.79 million +13.8%12.9%9 $24.72
7/31/20224,580,000 shares $111.11 million +16.8%12.6%8.2 $24.26
7/15/20223,920,000 shares $94.86 million +12.3%12.6%9.5 $24.20
6/30/20223,490,000 shares $74.37 million +5.8%11.3%8.6 $21.31
6/15/20223,300,000 shares $67.82 million +6.8%10.5%8.6 $20.55
5/31/20223,090,000 shares $64.52 million +6.2%9.8%8.8 $20.88
5/15/20222,910,000 shares $52.18 million -1.4%9.5%9.8 $17.93
4/30/20222,950,000 shares $59.56 million +3.2%9.6%10.5 $20.19
4/15/20222,860,000 shares $60.15 million -15.4%9.5%10.3 $21.03
3/31/20223,380,000 shares $65.10 million -9.1%12.1%12.5 $19.26
3/15/20223,720,000 shares $59.45 million +15.9%13.3%15.9 $15.98
2/28/20223,210,000 shares $57.14 million +3.2%11.4%15.8 $17.80
2/15/20223,110,000 shares $51.32 million +6.9%11.1%14.4 $16.50
1/31/20222,910,000 shares $43.97 million +26.0%10.6%14.5 $15.11
1/15/20222,310,000 shares $40.22 million +9.0%8.4%12.4 $17.41
12/31/20212,120,000 shares $43.97 million +7.1%7.7%12.7 $20.74
12/15/20211,980,000 shares $31.68 million No Change7.2%11.7 $16.00
11/30/20211,980,000 shares $32.81 million -1.0%7.2%12.1 $16.57
11/15/20212,000,000 shares $40.50 million +0.5%7.3%13.3 $20.25
10/29/20211,990,000 shares $42.15 million +1.0%7.2%14 $21.18
10/15/20211,970,000 shares $43.89 million -0.5%7.2%12.7 $22.28

ARQT Short Interest - Frequently Asked Questions

Short interest is the volume of Arcutis Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 18,458,091 shares of ARQT short. 16.21% of Arcutis Biotherapeutics' shares are currently sold short. Learn More on Arcutis Biotherapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARQT shares currently have a short interest ratio of 8.5. Learn More on Arcutis Biotherapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.21% of Arcutis Biotherapeutics' floating shares are currently sold short.

Arcutis Biotherapeutics saw a increase in short interest in September. As of September 15th, there was short interest totaling 18,458,091 shares, an increase of 11.5% from the previous total of 16,557,048 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

16.21% of Arcutis Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceuticals" compare to Arcutis Biotherapeutics: Corcept Therapeutics Incorporated (10.91%), Elanco Animal Health Incorporated (6.44%), Dr. Reddy's Laboratories Ltd (3.54%), Axsome Therapeutics, Inc. (7.55%), Crinetics Pharmaceuticals, Inc. (6.71%), Belite Bio, Inc. Sponsored ADR (3.01%), Lantheus Holdings, Inc. (6.29%), Amneal Pharmaceuticals, Inc. (4.27%), Liquidia Corporation (18.59%), Definium Therapeutics, Inc. (8.99%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.21 billion), Invesco QQQ ($46.31 billion), iShares Russell 2000 ETF ($27.98 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($9.70 billion), Canadian Natural Resources Limited ($9.42 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($8.53 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.79 billion), and Financial Select Sector SPDR Fund ($7.74 billion). View all of the most shorted stocks.

Short selling ARQT is an investing strategy that aims to generate trading profit from Arcutis Biotherapeutics as its price is falling. ARQT shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Arcutis Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ARQT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARQT, twice per month. The most recent reporting period available is September, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ARQT:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:ARQT is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/24/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Elon Warns "America Will Go Bankrupt". Trump's Plan Inside.
National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...
American Hartford Gold | Sponsoredtc pixel
How options let you do more with less capital
Would you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
WATCH THIS BEFORE DECEMBER 8th!!
James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...
Paradigm Press | Sponsoredtc pixel
How Elon’s Empire Ends (and how to profit)
Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel